Treatment strategies for the prevention of heart failure

Justin L. Grodin, W. H Wilson Tang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

With the astounding morbidity and mortality associated with heart failure (HF), preventive approaches have been explored. Controlling hypertension to prevent HF is well-established, especially with sodium restriction and thiazide-based antihypertensive therapies showing potential advantages. Control of dyslipidemia with aggressive statin therapy is particularly beneficial in preventing HF in the setting of acute coronary syndrome. The HOPE study also established the benefit of ACE inhibitors in the prevention of HF in high-risk subjects. Meanwhile old data supporting tight glycemic control in preventing HF have not been confirmed, suggesting the complexity of diabetic cardiomyopathy. Avoiding tobacco use and other known cardiotoxins are likely helpful. While there has been substantial development in identifying biomarkers predicting future development of HF, therapeutic interdiction guided by biomarker levels have yet to be established, even though it offers hope in modulating the natural history of the development of HF in at-risk individuals.

Original languageEnglish (US)
Pages (from-to)331-340
Number of pages10
JournalCurrent Heart Failure Reports
Volume10
Issue number4
DOIs
StatePublished - Dec 1 2013

Fingerprint

Heart Failure
Hope
Biomarkers
Cardiotoxins
Diabetic Cardiomyopathies
Thiazides
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Tobacco Use
Acute Coronary Syndrome
Dyslipidemias
Natural History
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Therapeutics
Sodium
Hypertension
Morbidity
Mortality

Keywords

  • Angiotensin converting enzyme inhibitor
  • Angiotensin receptor blocker
  • Beta-blocker
  • Biomarkers
  • Brain natriuretic peptide
  • Cardiomyopathy
  • Coronary artery disease
  • Diabetes mellitus
  • Heart failure
  • Hyperlipidemia
  • Hypertension
  • Insulin resistance
  • Left bundle branch block
  • Left ventricular hypertrophy
  • Obesity
  • Prevention
  • Statins
  • Thiazide diuretic
  • Troponin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)
  • Emergency Medicine

Cite this

Treatment strategies for the prevention of heart failure. / Grodin, Justin L.; Tang, W. H Wilson.

In: Current Heart Failure Reports, Vol. 10, No. 4, 01.12.2013, p. 331-340.

Research output: Contribution to journalArticle

@article{24f358252d9d4470b7b4729a0db4227e,
title = "Treatment strategies for the prevention of heart failure",
abstract = "With the astounding morbidity and mortality associated with heart failure (HF), preventive approaches have been explored. Controlling hypertension to prevent HF is well-established, especially with sodium restriction and thiazide-based antihypertensive therapies showing potential advantages. Control of dyslipidemia with aggressive statin therapy is particularly beneficial in preventing HF in the setting of acute coronary syndrome. The HOPE study also established the benefit of ACE inhibitors in the prevention of HF in high-risk subjects. Meanwhile old data supporting tight glycemic control in preventing HF have not been confirmed, suggesting the complexity of diabetic cardiomyopathy. Avoiding tobacco use and other known cardiotoxins are likely helpful. While there has been substantial development in identifying biomarkers predicting future development of HF, therapeutic interdiction guided by biomarker levels have yet to be established, even though it offers hope in modulating the natural history of the development of HF in at-risk individuals.",
keywords = "Angiotensin converting enzyme inhibitor, Angiotensin receptor blocker, Beta-blocker, Biomarkers, Brain natriuretic peptide, Cardiomyopathy, Coronary artery disease, Diabetes mellitus, Heart failure, Hyperlipidemia, Hypertension, Insulin resistance, Left bundle branch block, Left ventricular hypertrophy, Obesity, Prevention, Statins, Thiazide diuretic, Troponin",
author = "Grodin, {Justin L.} and Tang, {W. H Wilson}",
year = "2013",
month = "12",
day = "1",
doi = "10.1007/s11897-013-0154-8",
language = "English (US)",
volume = "10",
pages = "331--340",
journal = "Current Alzheimer Research",
issn = "1531-0035",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Treatment strategies for the prevention of heart failure

AU - Grodin, Justin L.

AU - Tang, W. H Wilson

PY - 2013/12/1

Y1 - 2013/12/1

N2 - With the astounding morbidity and mortality associated with heart failure (HF), preventive approaches have been explored. Controlling hypertension to prevent HF is well-established, especially with sodium restriction and thiazide-based antihypertensive therapies showing potential advantages. Control of dyslipidemia with aggressive statin therapy is particularly beneficial in preventing HF in the setting of acute coronary syndrome. The HOPE study also established the benefit of ACE inhibitors in the prevention of HF in high-risk subjects. Meanwhile old data supporting tight glycemic control in preventing HF have not been confirmed, suggesting the complexity of diabetic cardiomyopathy. Avoiding tobacco use and other known cardiotoxins are likely helpful. While there has been substantial development in identifying biomarkers predicting future development of HF, therapeutic interdiction guided by biomarker levels have yet to be established, even though it offers hope in modulating the natural history of the development of HF in at-risk individuals.

AB - With the astounding morbidity and mortality associated with heart failure (HF), preventive approaches have been explored. Controlling hypertension to prevent HF is well-established, especially with sodium restriction and thiazide-based antihypertensive therapies showing potential advantages. Control of dyslipidemia with aggressive statin therapy is particularly beneficial in preventing HF in the setting of acute coronary syndrome. The HOPE study also established the benefit of ACE inhibitors in the prevention of HF in high-risk subjects. Meanwhile old data supporting tight glycemic control in preventing HF have not been confirmed, suggesting the complexity of diabetic cardiomyopathy. Avoiding tobacco use and other known cardiotoxins are likely helpful. While there has been substantial development in identifying biomarkers predicting future development of HF, therapeutic interdiction guided by biomarker levels have yet to be established, even though it offers hope in modulating the natural history of the development of HF in at-risk individuals.

KW - Angiotensin converting enzyme inhibitor

KW - Angiotensin receptor blocker

KW - Beta-blocker

KW - Biomarkers

KW - Brain natriuretic peptide

KW - Cardiomyopathy

KW - Coronary artery disease

KW - Diabetes mellitus

KW - Heart failure

KW - Hyperlipidemia

KW - Hypertension

KW - Insulin resistance

KW - Left bundle branch block

KW - Left ventricular hypertrophy

KW - Obesity

KW - Prevention

KW - Statins

KW - Thiazide diuretic

KW - Troponin

UR - http://www.scopus.com/inward/record.url?scp=84888063398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888063398&partnerID=8YFLogxK

U2 - 10.1007/s11897-013-0154-8

DO - 10.1007/s11897-013-0154-8

M3 - Article

C2 - 24014140

AN - SCOPUS:84888063398

VL - 10

SP - 331

EP - 340

JO - Current Alzheimer Research

JF - Current Alzheimer Research

SN - 1531-0035

IS - 4

ER -